amaxa eNews #5   Issue: amaxa eNews #1 amaxa eNews #2 amaxa eNews #3 amaxa eNews #4 amaxa eNews #5 Article: Overview Application Note Review Product Information Presentation Meetings & Shows Request more Info Related FAQs Related Citations Citations on Nucleofection in Cancer Research The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4 Authors: de Bruijn DR, van Dijk AH, Willemse MP, van Kessel AG In: Oncogene (2008) 27(5): 653-62 BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module Authors: Park D, Tosello-Trampont AC, Elliott MR, Lu M, Haney LB, Ma Z, Klibanov AL, Mandell JW, Ravichandran KS In: Nature (2007) 450(7168): 430-434 Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas Authors: Lwin T, Hazlehurst LA, Dessureault S, Lai R, Bai W, Sotomayor E, Moscinski LC, Dalton WS, Tao J In: Blood (2007) 110(5): 1631-8 Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumors Authors: Sasaki K, Zhu X, Vasquez C, Nishimura F, Dusak JE, Huang J, Fujita M, Wesa A, Potter DM, Walker PR, Storkus WJ, Okada H In: Cancer Res (2007) 67(13): 6451-8 Easy stable transfection of a human cancer cell line by electrogene transfer with an Epstein-Barr virus-based plasmid vector Authors: Shibata MA, Miwa Y, Morimoto J, Otsuki Y In: Med Mol Morphol (2007) 40(2): 103-7 Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model Authors: Scaglione BJ, Salerno E, Balan M, Coffman F, Landgraf P, Abbasi F, Kotenko S, Marti GE, Raveche ES In: Br J of Haematol (2007) 139(5): 645-57 Tumor cell apoptosis polarizes macrophages role of sphingosine-1-phosphate Authors: Weigert A, Tzieply N, von Knethen A, Johann AM, Schmidt H, Geisslinger G, Brüne B In: Mol Biol Cell (2007) 18(10): 3810-9 Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids Authors: Seiffert M, Stilgenbauer S, Döhner H, Lichter P In: Leukemia (2007) 21(9): 1977-83 RNAi screen identifies UBE2D3 as a mediator of all-trans retinoic acid-induced cell growth arrest in human acute promyelocytic NB4 cells Authors: Hattori H, Zhang X, Jia Y, Subramanian KK, Jo H, Loison F, Newburger PE, Luo HR In: Blood (2007) 110(2): 640-50 Targeting of gene expression by siRNA in CML primary cells Authors: Merkerova M, Klamova H, Brdicka R, Bruchova H In: Mol Biol Rep (2007) 34(1): 27-33 IFI16 in Human Prostate Cancer Authors: Alimirah F, Chen J, Davis FJ, Choubey D In: Mol Cancer Res (2007) 5(3): 251-9 Inhibition of Tumor Necrosis Factor--Inducible Inflammatory Genes by Interferon- Is Associated with Altered Nuclear Factor-B Transactivation and Enhanced Histone Deacetylase Activity Authors: Keslacy S, Tliba O, Baidouri H, Amrani Y In: Mol Pharmacol (2007) 71(2): 609-618 Ability to Acquire Drug Resistance Arises Early during the Tumorigenesis Process Authors: Yague E, Arance A, Kubitza L, O'hare M, Jat P, Ogilvie CM, Hart IR, Higgins CF, Raguz S In: Cancer Res (2007) 67(3): 1130-7 Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells Authors: Yochum GS, McWeeney S, Rajaraman V, Cleland R, Peters S, Goodman RH In: Proc Natl Acad Sci USA (2007) 104(9): 3324-9 For more citations go to our citations database. Subscribe Subscribe here to receive future issues of amaxa eNews. Invite a friend Recommend amaxa's eNews to a friend or colleague. The Nucleofector Technology, comprising Nucleofection Process, Nucleofector Device, Nucleofector Solutions, Nucleofector 96-well Shuttle System and Nucleocuvette plates and modules is covered by patent and/or patent pending rights owned by amaxa AG. amaxa, Nucleofector, nucleofection, maxGFP, 96-well Shuttle and Nucleocuvette are either registered trademarks or trademarks of amaxa AG in the U.S. and/or Germany and/or other countries. Other product and company names mentioned herein are the trademarks of their respective owners. amaxa disclaims all warranties, whether expressed or implied, including any warranty as to the quality, accuracy, safety, or suitability of the information provided in this e-newsletter for any particular purpose. Any use of the information contained on any page of this e-newsletter is evidence of agreement with these terms of use.